Enhanc3D Genomics has appointed former AstraZeneca figure Dr Hazel Jones as its permanent CEO. Dr Jones has led the Cambridge MedTech, developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, as interim CEO and COO for the last six months. Dr Jones has overseen the company’s global business operations and … Continue reading Former AstraZeneca figure named CEO at Cambridge MedTech